Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London, United Kingdom.
Mov Disord. 2010 Apr 15;25(5):570-7. doi: 10.1002/mds.22688.
Previous studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondemented Parkinson's disease (PD) and 126 controls. Mean UPSIT scores in PSP were lower than in controls (P < 0.001) but higher than in PD (P < 0.001) after adjusting for age, gender, and smoking history. For patients with PSP, UPSIT scores correlated with MMSE (r = 0.44, P = 0.006) but not disease duration (P = 0.6), motor subscale of the Unified Parkinson's Disease Rating Scale (P = 0.2), or Frontal Assessment Battery (P = 0.5). The brains of six of the patients with PSP were examined postmortem and all revealed neurofibrillary tangles and tau accumulation in the rhinencephalon, although only three had hyposmia. Further prospective studies including patients with early PSP and PSP-P with postmortem confirmation might help clarify if smell tests could be useful when the differential diagnosis lies between PD and PSP.
先前的研究表明,在进行性核上性麻痹(PSP)中嗅觉是正常的。我们应用宾夕法尼亚大学嗅觉识别测试(UPSIT)对 36 名 MMSE 评分大于 18 分的 PSP 患者、140 名非痴呆帕金森病(PD)患者和 126 名对照者进行了测试。在调整年龄、性别和吸烟史后,PSP 患者的 UPSIT 评分低于对照组(P < 0.001),但高于 PD 组(P < 0.001)。对于 PSP 患者,UPSIT 评分与 MMSE 相关(r = 0.44,P = 0.006),但与疾病持续时间(P = 0.6)、帕金森病评定量表(Unified Parkinson's Disease Rating Scale)的运动子量表(P = 0.2)或额叶评估量表(Frontal Assessment Battery)(P = 0.5)无关。6 名 PSP 患者的大脑接受了尸检检查,所有患者的嗅球均显示出神经纤维缠结和 tau 积聚,尽管只有 3 名患者存在嗅觉减退。进一步包括早期 PSP 和 PSP-P 患者的前瞻性研究并进行尸检确认,可能有助于阐明当鉴别诊断介于 PD 和 PSP 之间时,嗅觉测试是否有用。